SeaStar Medical Holding Corporation (ICU) vs Satellos Bioscience Inc. (MSLE)
A side-by-side comparison of SeaStar Medical Holding Corporation and Satellos Bioscience Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICU
SeaStar Medical Holding Corporation
$3.20HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
MSLE
Satellos Bioscience Inc.
$8.08HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — ICU vs MSLE
growth of $100 · dividends reinvested · last 1yICU +54.3% (+54.3%/yr)MSLE +13.7% (+13.7%/yr)ICU compounded faster over this window
ICU MSLE
ICU vs MSLE: by the numbers
- •MSLE is the larger company ($10M vs $9M market cap).
- •Both run net losses; MSLE's is the smaller (0.00% vs -795.50% net margin).
Metrics side by side
Valuation
| Metric | ICU | MSLE |
|---|---|---|
| P/S ratio | 5.31 | N/A |
| P/B ratio | 2.12 | 0.17 |
Profitability
| Metric | ICU | MSLE |
|---|---|---|
| Gross margin | 92.64% | 0.00% |
| Operating margin | -986.63% | 0.00% |
| Net margin | -795.50% | 0.00% |
| ROE | -317.20% | -57.34% |
| ROIC | -325.63% | -59.35% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.